{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:11:40Z","timestamp":1788595900236,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,5]]},"DOI":"10.7759\/cureus.115807","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:32:56Z","timestamp":1788593576000},"source":"Crossref","is-referenced-by-count":0,"title":["From Fecal Microbial Potential to Circulating Trimethylamine N-oxide and Cardiovascular Events: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Ruxandra Florentina","family":"Ionescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda Maria","family":"Cretoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang Z","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, et al.. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011, 472:57-63. 10.1038\/nature09922","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang WH","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, et al.. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013, 368:1575-84. 10.1056\/NEJMoa1109400","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth RA","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, et al.. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013, 19:576-85. 10.1038\/nm.3145","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett BJ","year":"2013","unstructured":"Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al.. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013, 17:49-60. 10.1016\/j.cmet.2012.12.011","journal-title":"Cell Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu W","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, et al.. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016, 165:111-24. 10.1016\/j.cell.2016.02.011","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang Z","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, et al.. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015, 163:1585-95. 10.1016\/j.cell.2015.11.055","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella GG","year":"2017","unstructured":"Schiattarella GG, Sannino A, Toscano E, et al.. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J. 2017, 38:2948-56. 10.1093\/eurheartj\/ehx342","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Heianza Y","year":"2017","unstructured":"Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Heart Assoc. 2017, 6:e004947. 10.1161\/JAHA.116.004947","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi J","year":"2018","unstructured":"Qi J, You T, Li J, Pan T, Xiang L, Han Y, Zhu L. Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies. J Cell Mol Med. 2018, 22:185-94. 10.1111\/jcmm.13307","journal-title":"J Cell Mol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.103908","article-title":"Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: umbrella review of published systematic reviews and meta-analyses","volume":"35","author":"Obeid R","year":"2025","unstructured":"Obeid R, Mohr L, White BA, Heine GH, Emrich I, Geisel J, Carter RC. Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: umbrella review of published systematic reviews and meta-analyses. Nutr Metab Cardiovasc Dis. 2025, 35:103908. 10.1016\/j.numecd.2025.103908","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05903-3","article-title":"Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of atherosclerosis","volume":"15","author":"Budoff MJ","year":"2025","unstructured":"Budoff MJ, de Oliveira Otto MC, Li XS, et al.. Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of atherosclerosis. Sci Rep. 2025, 15:23362. 10.1038\/s41598-025-05903-3","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029230","article-title":"Plasma trimethylamine-N-oxide and incident ischemic stroke: the cardiovascular health study and the multi-ethnic study of atherosclerosis","volume":"12","author":"Lemaitre RN","year":"2023","unstructured":"Lemaitre RN, Jensen PN, Wang Z, et al.. Plasma trimethylamine-N-oxide and incident ischemic stroke: the cardiovascular health study and the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2023, 12:e8711. 10.1161\/JAHA.122.029230","journal-title":"J Am Heart Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13550","article-title":"Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease","volume":"292","author":"Bj\u00f8rnestad E\u00d8","year":"2022","unstructured":"Bj\u00f8rnestad E\u00d8, Dhar I, Svingen GF, et al.. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. J Intern Med. 2022, 292:915-24. 10.1111\/joim.13550","journal-title":"J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01368-y","article-title":"Circulating TMAO, the gut microbiome and cardiometabolic disease risk: an exploration in key precursor disorders","volume":"16","author":"Naghipour S","year":"2024","unstructured":"Naghipour S, Cox AJ, Fisher JJ, et al.. Circulating TMAO, the gut microbiome and cardiometabolic disease risk: an exploration in key precursor disorders. Diabetol Metab Syndr. 2024, 16:133. 10.1186\/s13098-024-01368-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2025.100453","article-title":"The effect of red meat consumption on circulating, urinary, and fecal trimethylamine-N-oxide: a systematic review and narrative synthesis of randomized controlled trials","volume":"16","author":"Jafari F","year":"2025","unstructured":"Jafari F, Damani JJ, Petersen KS. The effect of red meat consumption on circulating, urinary, and fecal trimethylamine-N-oxide: a systematic review and narrative synthesis of randomized controlled trials. Adv Nutr. 2025, 16:100453. 10.1016\/j.advnut.2025.100453","journal-title":"Adv Nutr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61101767","article-title":"TMAO and cardiovascular disease: exploring its potential as a biomarker","volume":"61","author":"Amaritei O","year":"2025","unstructured":"Amaritei O, Mierlan OL, Dinu CA, Chiscop I, Matei MN, Gutu C, Gurau G. TMAO and cardiovascular disease: exploring its potential as a biomarker. Medicina (Kaunas). 2025, 61:1767. 10.3390\/medicina61101767","journal-title":"Medicina (Kaunas)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1690411","article-title":"Gut microbiota on cardiovascular diseases-a mini review on current evidence","volume":"16","author":"Zhang S","year":"2025","unstructured":"Zhang S, Li J, Li L, Yuan X. Gut microbiota on cardiovascular diseases-a mini review on current evidence. Front Microbiol. 2025, 16:1690411. 10.3389\/fmicb.2025.1690411","journal-title":"Front Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9091913","article-title":"Gut microbiome, functional food, atherosclerosis, and vascular calcifications-is there a missing link?","volume":"9","author":"Cretoiu D","year":"2021","unstructured":"Cretoiu D, Ionescu RF, Enache RM, Cretoiu SM, Voinea SC. Gut microbiome, functional food, atherosclerosis, and vascular calcifications-is there a missing link?. Microorganisms. 2021, 9:1913. 10.3390\/microorganisms9091913","journal-title":"Microorganisms"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.856901","article-title":"The interplay between gut microbiota and miRNAs in cardiovascular diseases","volume":"9","author":"Ionescu RF","year":"2022","unstructured":"Ionescu RF, Enache RM, Cretoiu SM, Cretoiu D. The interplay between gut microbiota and miRNAs in cardiovascular diseases. Front Cardiovasc Med. 2022, 9:856901. 10.3389\/fcvm.2022.856901","journal-title":"Front Cardiovasc Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.110642","article-title":"Intestinal microbiomics in physiological and pathological conditions","author":"Ionescu RF","year":"2023","unstructured":"Ionescu RF, Cozma EC, Enache RM, et al.. Intestinal microbiomics in physiological and pathological conditions. Advances in Probiotics for Health and Nutrition. Zambare V, Md Din MF, Gupta P, et al. (ed): IntechOpen, London, UK; 2023. 10.5772\/intechopen.110642"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02966","article-title":"Potential TMA-producing bacteria are ubiquitously found in Mammalia","volume":"10","author":"Rath S","year":"2019","unstructured":"Rath S, Rud T, Pieper DH, Vital M. Potential TMA-producing bacteria are ubiquitously found in Mammalia. Front Microbiol. 2019, 10:2966. 10.3389\/fmicb.2019.02966","journal-title":"Front Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317155","article-title":"Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice","volume":"68","author":"Wu WK","year":"2019","unstructured":"Wu WK, Chen CC, Liu PY, et al.. Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice. Gut. 2019, 68:1439-49. 10.1136\/gutjnl-2018-317155","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021934","article-title":"Fecal microbiome composition does not predict diet-induced TMAO production in healthy adults","volume":"10","author":"Ferrell M","year":"2021","unstructured":"Ferrell M, Bazeley P, Wang Z, et al.. Fecal microbiome composition does not predict diet-induced TMAO production in healthy adults. J Am Heart Assoc. 2021, 10:e021934. 10.1161\/JAHA.121.021934","journal-title":"J Am Heart Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/nu14071376","article-title":"Diet, fecal microbiome, and trimethylamine N-oxide in a cohort of metabolically healthy United States adults","volume":"14","author":"James KL","year":"2022","unstructured":"James KL, Gertz ER, Cervantes E, Bonnel EL, Stephensen CB, Kable ME, Bennett BJ. Diet, fecal microbiome, and trimethylamine N-oxide in a cohort of metabolically healthy United States adults. Nutrients. 2022, 14:1376. 10.3390\/nu14071376","journal-title":"Nutrients"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010062","article-title":"Urinary TMAO levels are associated with the taxonomic composition of the gut microbiota and with the choline TMA-lyase gene (cutC) harbored by Enterobacteriaceae","volume":"12","author":"Dalla Via A","year":"2019","unstructured":"Dalla Via A, Gargari G, Taverniti V, et al.. Urinary TMAO levels are associated with the taxonomic composition of the gut microbiota and with the choline TMA-lyase gene (cutC) harbored by Enterobacteriaceae. Nutrients. 2019, 12:62. 10.3390\/nu12010062","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0461-0","article-title":"Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota","volume":"6","author":"Hoyles L","year":"2018","unstructured":"Hoyles L, Jim\u00e9nez-Pranteda ML, Chilloux J, et al.. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Microbiome. 2018, 6:73. 10.1186\/s40168-018-0461-0","journal-title":"Microbiome"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1643515","article-title":"Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease","volume":"50","author":"Phillips IR","year":"2020","unstructured":"Phillips IR, Shephard EA. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease. Xenobiotica. 2020, 50:19-33. 10.1080\/00498254.2019.1643515","journal-title":"Xenobiotica"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3189","article-title":"In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene","volume":"73","author":"Lambert DM","year":"2001","unstructured":"Lambert DM, Mamer OA, Akerman BR, Choini\u00e8re L, Gaudet D, Hamet P, Treacy EP. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene. Mol Genet Metab. 2001, 73:224-9. 10.1006\/mgme.2001.3189","journal-title":"Mol Genet Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161074","article-title":"Association of FMO3 variants and trimethylamine N-oxide concentration, disease progression, and mortality in CKD patients","volume":"11","author":"Robinson-Cohen C","year":"2016","unstructured":"Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK. Association of FMO3 variants and trimethylamine N-oxide concentration, disease progression, and mortality in CKD patients. PLoS One. 2016, 11:e0161074. 10.1371\/journal.pone.0161074","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600324","article-title":"Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial","volume":"61","author":"Cho CE","year":"2017","unstructured":"Cho CE, Taesuwan S, Malysheva OV, et al.. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 2017, 61:1600324. 10.1002\/mnfr.201600324","journal-title":"Mol Nutr Food Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy799","article-title":"Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women","volume":"40","author":"Wang Z","year":"2019","unstructured":"Wang Z, Bergeron N, Levison BS, et al.. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2019, 40:583-94. 10.1093\/eurheartj\/ehy799","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang WH","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, et al.. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015, 116:448-55. 10.1161\/CIRCRESAHA.116.305360","journal-title":"Circ Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014111063","article-title":"Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden","volume":"27","author":"Stubbs JR","year":"2016","unstructured":"Stubbs JR, House JA, Ocque AJ, et al.. Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. J Am Soc Nephrol. 2016, 27:305-13. 10.1681\/ASN.2014111063","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13739-9","article-title":"TMAO is associated with mortality: impact of modestly impaired renal function","volume":"7","author":"Gruppen EG","year":"2017","unstructured":"Gruppen EG, Garcia E, Connelly MA, Jeyarajah EJ, Otvos JD, Bakker SJ, Dullaart RP. TMAO is associated with mortality: impact of modestly impaired renal function. Sci Rep. 2017, 7:13781. 10.1038\/s41598-017-13739-9","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.096","article-title":"A multi-omic association study of trimethylamine N-oxide","volume":"24","author":"Manor O","year":"2018","unstructured":"Manor O, Zubair N, Conomos MP, et al.. A multi-omic association study of trimethylamine N-oxide. Cell Rep. 2018, 24:935-46. 10.1016\/j.celrep.2018.06.096","journal-title":"Cell Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39824-4","article-title":"Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide","volume":"14","author":"Andrikopoulos P","year":"2023","unstructured":"Andrikopoulos P, Aron-Wisnewsky J, Chakaroun R, et al.. Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide. Nat Commun. 2023, 14:5843. 10.1038\/s41467-023-39824-4","journal-title":"Nat Commun"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0153","article-title":"Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional Mendelian randomization analysis","volume":"68","author":"Jia J","year":"2019","unstructured":"Jia J, Dou P, Gao M, Kong X, Li C, Liu Z, Huang T. Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional Mendelian randomization analysis. Diabetes. 2019, 68:1747-55. 10.2337\/db19-0153","journal-title":"Diabetes"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.922441","article-title":"Trimethylamine N-oxide and its precursors in relation to blood pressure: a Mendelian randomization study","volume":"9","author":"Wang H","year":"2022","unstructured":"Wang H, Luo Q, Ding X, Chen L, Zhang Z. Trimethylamine N-oxide and its precursors in relation to blood pressure: a Mendelian randomization study. Front Cardiovasc Med. 2022, 9:922441. 10.3389\/fcvm.2022.922441","journal-title":"Front Cardiovasc Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang WH","year":"2014","unstructured":"Tang WH, Wang Z, Fan Y, et al.. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014, 64:1908-14. 10.1016\/j.jacc.2014.02.617","journal-title":"J Am Coll Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002816","article-title":"Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE-like patient cohort","volume":"5","author":"Senthong V","year":"2016","unstructured":"Senthong V, Wang Z, Li XS, Fan Y, Wu Y, Tang WH, Hazen SL. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE-like patient cohort. J Am Heart Assoc. 2016, 5:002816. 10.1161\/JAHA.115.002816","journal-title":"J Am Heart Assoc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw582","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li XS","year":"2017","unstructured":"Li XS, Obeid S, Klingenberg R, et al.. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017, 38:814-24. 10.1093\/eurheartj\/ehw582","journal-title":"Eur Heart J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311023","article-title":"Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes","volume":"38","author":"Haghikia A","year":"2018","unstructured":"Haghikia A, Li XS, Liman TG, et al.. Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler Thromb Vasc Biol. 2018, 38:2225-35. 10.1161\/ATVBAHA.118.311023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1000815","article-title":"Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: mediating effects of renal function","volume":"9","author":"Sanchez-Gimenez R","year":"2022","unstructured":"Sanchez-Gimenez R, Peir\u00f3 \u00d3M, Bonet G, et al.. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: mediating effects of renal function. Front Cardiovasc Med. 2022, 9:1000815. 10.3389\/fcvm.2022.1000815","journal-title":"Front Cardiovasc Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB","volume":"5","author":"Seldin MM","year":"2016","unstructured":"Seldin MM, Meng Y, Qi H, et al.. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. J Am Heart Assoc. 2016, 5:002767. 10.1161\/JAHA.115.002767","journal-title":"J Am Heart Assoc"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006347","article-title":"Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway","volume":"6","author":"Chen ML","year":"2017","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017, 6:006347. 10.1161\/JAHA.117.006347","journal-title":"J Am Heart Assoc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.087692","article-title":"Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study","volume":"100","author":"Miller CA","year":"2014","unstructured":"Miller CA, Corbin KD, da Costa KA, et al.. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr. 2014, 100:778-86. 10.3945\/ajcn.114.087692","journal-title":"Am J Clin Nutr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts AB","year":"2018","unstructured":"Roberts AB, Gu X, Buffa JA, et al.. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018, 24:1407-17. 10.1038\/s41591-018-0128-1","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.06.003","article-title":"NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting","volume":"50","author":"Garcia E","year":"2017","unstructured":"Garcia E, Wolak-Dinsmore J, Wang Z, et al.. NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting. Clin Biochem. 2017, 50:947-55. 10.1016\/j.clinbiochem.2017.06.003","journal-title":"Clin Biochem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI201684","article-title":"Gut microbial trimethylamine N-oxide generation promotes risk of atrial fibrillation via muscarinic receptor-mediated autonomic dysfunction","author":"Arjunan S","year":"2026","unstructured":"Arjunan S, Pemberton I, Li XS, et al.. Gut microbial trimethylamine N-oxide generation promotes risk of atrial fibrillation via muscarinic receptor-mediated autonomic dysfunction. J Clin Invest. 2026, e201684. 10.1172\/JCI201684","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522332-from-fecal-microbial-potential-to-circulating-trimethylamine-n-oxide-and-cardiovascular-events-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:32:57Z","timestamp":1788593577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522332-from-fecal-microbial-potential-to-circulating-trimethylamine-n-oxide-and-cardiovascular-events-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.115807","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,5]]}}}